Home » Newsletters » BioWorld Science

BioWorld Science

March 15, 2012

View Archived Issues

Peptide inhibitor nanoparticles reduce beta-amyloid aggregation in preclinical study

NME protects human bone marrow progenitor cells against radiation

Endocyte to file conditional MAAs in E.U. for anticancer therapeutic and imaging agent

Cell>Point receives SPA agreement from FDA for imaging agent

HIV peptide-loaded dendritic cells evaluated in DALIA trial

Alkermes Pharma Ireland withdraws megestrol MAA

Oncothyreon starts phase I ONT-10 cancer vaccine trial

BioFocus, Argenta and AstraZeneca enter new research agreement

Okairos launches NIH-funded phase I/II trial of HCV vaccine

Epizyme achieves preclinical milestone in mixed-lineage leukemia

Phase II program for heart failure to proceed

Threshold Pharmaceuticals treats first patient in multiple myeloma study

Millennium Pharmaceuticals designs novel PI3K and mTOR inhibitors

FDA approves first effervescent osteoporosis drug

New metabotropic glutamate mGlu2 receptor antagonists developed

New apoptosis inducers divulged

Scientists from Varinel discover novel iron chelators

Domain Therapeutics announces new funding for schizophrenia project

Intercell kicks off phase II/III study of vaccine candidate

Foamix product demonstrates efficacy in phase II trial in impetigo

Novel potential hepatitis C therapies identified at Bristol-Myers Squibb

Boehringer Ingelheim patents new bradykinin B1 receptor antagonists

Novel mineralocorticoid receptor antagonists presented by KBP BioSciences

Amgen reports new myostatin-binding antibodies

Shire withdraws BLA for Fabry's disease therapy

First oral contraceptive for heavy menstrual bleeding approved in U.S.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...